Malignant Mesothelioma
(Sprache: Englisch)
Malignant Mesothelioma brings together the most current diagnostic criteria and treatment plans from the world's leading experts on this rare but devastating cancer. The first edition was a critical and commercial success and this revision builds on that...
Leider schon ausverkauft
versandkostenfrei
Buch
213.99 €
Produktdetails
Produktinformationen zu „Malignant Mesothelioma “
Klappentext zu „Malignant Mesothelioma “
Malignant Mesothelioma brings together the most current diagnostic criteria and treatment plans from the world's leading experts on this rare but devastating cancer. The first edition was a critical and commercial success and this revision builds on that reputation. The editors have brought together the world's leading experts to fully explore the latest scientific breakthroughs in carcinogenesis, immunotherapy, potential vaccination strategies, and gene therapy. The clinical aspects of the book are equally strong, with thorough discussion of epidemiology, etiology, different clinical presentations, imaging (including interventional pulmonology), treatment of benign disease, strategies for multimodality treatment of malignant disease.
Editors: Harvey I. Pass, M.D, Chief, Thoracic Surgery, New York University, New York, NY; Nicholas Vogelzang, M.D, Director, Nevada Cancer Institute, Las Vegas, NV; University of Chicago, Michele Carbone, M.D., Ph.D, Researcher and Director, Thoracic Oncology Program, Cancer Research Center of Hawaii, Honolulu, HI; and Anne S. Tsao, M.D, Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
Malignant mesothelioma is a rare form of cancer, in which the cancer cells are found in the sac lining the chest (pleura) or abdomen (peritoneum). This lethal disease is associated with asbestos and has vast economic and legal implications. As the disease takes approximately twenty years to manifest itself in humans, a wave of diagnoses is expected in the near future. In the United States alone, an estimated 3,500 - 4,000 patients are diagnosed with mesothelioma annually, and it is estimated that over the next 35 years, more than 250,000 people in Western Europe will be diagnosed with the disease. Malignant Mesothelioma, edited by internationally recognized experts in the field, is a comprehensive text that relates science, pathology, clinical aspects and therapy for mesothelioma under one cover. The book integrates the newest research and advances in its discussions of the disease, covering such topics as carcinogenesis, epidemiology, benchwork, endoscopy, multimodality approaches and treatment. It includes discussions on novel approaches to mesothelioma, such as gene therapy, vaccination strategies and immunotherapy, as well as discussions on the legal and economic aspects of the disease. Over 200 illustrations round out the text. An invaluable reference for the medical oncologist, thoracic surgeon, radiation oncologist, pulmonologist, and benchworker interested in the disease.
Inhaltsverzeichnis zu „Malignant Mesothelioma “
I. Carcinogenesis: Asbestos Carcinogenesis- SV40 Carcinogenesis
- Other causes of mesothelioma
- Inherited Mesothelioma
II. Epidemiology: Pleural
- Testicular
- Abdominal
- Pericardial
III. Benchwork: Mesothelioma Cell Lines
- Mesothelioma in vivo models
- Cytogenetics
- Growth Factors
- Oncogenes
- Tumor Suppressor Genes
- Immune Status
- Angiogenesis
- Metallomatrix Proteins
- Mesothelioma Genomics
IV. Clinical Presentation: Pleural and Pericardial
- Abdominal
V. Endoscopy: Laparoscopy
- Thoracoscopy
VI. Imaging: Routine Roentgenography
- Computerized Tomography
- PET Scanning
- MRI
VII. Pathology: Standard Morphology and Architecture
- Special Stains
- Cytology
- Electron Microscopy
VIII. Treatment
IX. Natural History
X. General Strategies for the Management of Benign Variants of Mesothelioma
XI. General Treatment Strategies: Chemotherapy
- Radiation
- Immunotherapy
- Surgery
XII. Multimodality Approaches for Pleural Mesothelioma: Preoperative Chemotherapy and Surgery
- Surgery and Intraoperative Chemotherapy
- Surgery and Intraoperative Photodynamic Therapy.
Bibliographische Angaben
- 2005, 854 Seiten, Maße: 25,4 cm, Gebunden, Englisch
- Herausgegeben:Pass, Harvey I.; Vogelzang, Nicholas; Carbone, Michele
- Verlag: Springer, New York
- ISBN-10: 0387229493
- ISBN-13: 9780387229492
Sprache:
Englisch
Rezension zu „Malignant Mesothelioma “
From the reviews:"Malignant Mesothelioma is an uncommon neoplasm usually associated with exposure to asbestos. ... Harvey Pass and colleagues have edited an up-to-date, comprehensive book that includes a wide range of information, from a historical perspective to descriptions of the latest treatment. ... Laboratory researchers will use it as a resource for information ... of mesothelioma. ... Clinicians will benefit from this complete guide ... . I highly recommend this book to all those who are interested in mesothelioma." (Julie R. Brahmer, The New England Journal of Medicine, March, 2006)
"This is a reference book suitable for departmental and medical libraries and for the shelves of those who have a particular clinical or research interest in mesothelioma ... . Pass, Vogelzang and Carbone envisioned a comprehensive text and have achieved it. ... To be useful such a book must be well indexed; and this is. The individual chapters are well referenced ... . The text is well edited ... . This is a quality production. ... Overall it is highly recommended." (Michael Byrne, CancerForum, Vol. 30 (3), November, 2006)
Kommentar zu "Malignant Mesothelioma"
0 Gebrauchte Artikel zu „Malignant Mesothelioma“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Malignant Mesothelioma".
Kommentar verfassen